Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and Di Guglielmo Disease

thiazoles has been researched along with Di Guglielmo Disease in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's6 (60.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cools, J; De Keersmaecker, K; Hantschel, O; Superti-Furga, G; Versele, M1
Fishelson, Z; Koya, K; Pilzer, D; Saar, M1
Benfica, PL; de Lima, AP; dos Santos, WB; Lacerda, Ede P; Mello, FM; Pavanin, LA; Pereira, Fde C; Ribeiro, Ade S; Valadares, MC; Vilanova-Costa, CA1
Flynn, KM; Fornelli, F; Minervini, F1
Darghal, N; Garnier-Suillerot, A; Salerno, M1
Craig, J; Cunningham, J; Gelly, K; Pippard, MJ; Sales, M; Tauro, S; Walker, K1
Hildebrandt, A; Lawen, A; Schwabe, K; Steinheider, G; Traber, R1
Guo, DS; Hu, ZY; Wang, HC; Wen, XX; Zhao, YW1
Hirase, N; Mu, Y; Muta, K; Nawata, H; Takayanagi, R; Umemura, T; Yanase, T1
Hishinuma, T; Mizugaki, M; Yamazaki, T1

Other Studies

10 other study(ies) available for thiazoles and Di Guglielmo Disease

ArticleYear
Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.
    Leukemia, 2008, Volume: 22, Issue:12

    Topics: Benzamides; Dasatinib; Enzyme Activation; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; In Vitro Techniques; K562 Cells; Leukemia, Erythroblastic, Acute; Oncogene Proteins, Fusion; Phosphorylation; Piperazines; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Substrate Specificity; Thiazoles

2008
Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.
    International journal of cancer, 2010, Mar-15, Volume: 126, Issue:6

    Topics: Animals; Bacterial Proteins; Blotting, Western; Calcimycin; Cell Survival; Complement C9; Dose-Response Relationship, Drug; HCT116 Cells; Hemolysis; HSP70 Heat-Shock Proteins; Humans; Ionophores; K562 Cells; Leukemia, Erythroblastic, Acute; Pyridines; Rabbits; Recombinant Proteins; RNA Interference; Streptolysins; Thiazoles

2010
The compound cis-(dichloro)tetrammineruthenium(III) chloride induces caspase-mediated apoptosis in K562 cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2010, Volume: 24, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle; Cell Survival; Cyclosporine; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Ruthenium Compounds; Tetrazolium Salts; Thiazoles; Trypan Blue; Tumor Stem Cell Assay

2010
Toxicity and apoptosis induced by the mycotoxins nivalenol, deoxynivalenol and fumonisin B1 in a human erythroleukemia cell line.
    Toxicology in vitro : an international journal published in association with BIBRA, 2004, Volume: 18, Issue:1

    Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Differentiation; Cell Division; Cell Membrane; Cell Physiological Phenomena; Cell Survival; Cycloheximide; DNA Replication; Dose-Response Relationship, Drug; Flow Cytometry; Fumonisins; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Mitochondria; Mycotoxins; Tetrazolium Salts; Thiazoles; Trichothecenes; Trypan Blue

2004
Mechanism of thioflavin T accumulation inside cells overexpressing P-glycoprotein or multidrug resistance-associated protein: role of lipophilicity and positive charge.
    Biochemical and biophysical research communications, 2006, May-05, Volume: 343, Issue:2

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzothiazoles; Blood-Brain Barrier; Cell Line, Tumor; Cell Membrane; Humans; Leukemia, Erythroblastic, Acute; Lipid Metabolism; Metabolic Clearance Rate; Multidrug Resistance-Associated Proteins; Static Electricity; Thiazoles

2006
Sequential tyrosine kinase inhibitor therapy: sustained disease remission in Philadelphia-positive erythroleukaemia.
    British journal of haematology, 2008, Volume: 142, Issue:4

    Topics: Benzamides; Dasatinib; Female; Humans; Imatinib Mesylate; Leukemia, Erythroblastic, Acute; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles

2008
Reversal of multidrug resistance by novel cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro.
    Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:7

    Topics: Cyclosporins; Dactinomycin; Doxorubicin; Drug Interactions; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Friend murine leukemia virus; Humans; Immunosuppressive Agents; Leukemia, Erythroblastic, Acute; Lymphoma; Rhodamine 123; Rhodamines; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

1995
[Synthesis of N-substituted polymethylene dicarboxamides as inducers of differentiation].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1993, Volume: 28, Issue:3

    Topics: Animals; Antineoplastic Agents; Caprylates; Cell Differentiation; Decanoates; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Mice; Pyridones; Thiazoles; Tumor Cells, Cultured

1993
Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562.
    Leukemia research, 2000, Volume: 24, Issue:5

    Topics: Cell Differentiation; Erythrocytes; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Ligands; Nuclear Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Thiazoles; Thiazolidinediones; Transcription Factors

2000
Troglitazone has a reducing effect on thromboxane production.
    Prostaglandins & other lipid mediators, 2000, Volume: 62, Issue:2

    Topics: Arachidonic Acid; Blood Platelets; Chromans; Diabetes Mellitus, Type 2; Fibrinolytic Agents; Gas Chromatography-Mass Spectrometry; Humans; Leukemia, Erythroblastic, Acute; Rosiglitazone; Thiazoles; Thiazolidinediones; Thromboxane A2; Troglitazone; Tumor Cells, Cultured; Vitamin E

2000